These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 9346651

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The MEGX test: a tool for the real-time assessment of hepatic function.
    Oellerich M, Armstrong VW.
    Ther Drug Monit; 2001 Apr; 23(2):81-92. PubMed ID: 11294522
    [Abstract] [Full Text] [Related]

  • 4. Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors.
    Zotz RB, von Schönfeld J, Erhard J, Breuer N, Lange R, Beste M, Goebell H, Eigler FW.
    Transplantation; 1997 Feb 27; 63(4):538-41. PubMed ID: 9047147
    [Abstract] [Full Text] [Related]

  • 5. Use of monoethylglycinexylidide as a liver function test in the liver transplant recipient.
    Potter JM, Hickman PE, Lynch SV, Henderson A, Wright M, Balderson G, Strong RW.
    Transplantation; 1993 Dec 27; 56(6):1385-8. PubMed ID: 8279008
    [Abstract] [Full Text] [Related]

  • 6. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.
    Oellerich M, Burdelski M, Lautz HU, Schulz M, Schmidt FW, Herrmann H.
    Ther Drug Monit; 1990 May 27; 12(3):219-26. PubMed ID: 2349604
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic value of the monoethylglycinexylidide liver function test in assessing donor liver suitability.
    Fairchild R, Solomon H, Contis J, Kaminski D.
    Arch Surg; 1996 Oct 27; 131(10):1099-102. PubMed ID: 8857911
    [Abstract] [Full Text] [Related]

  • 9. The use of the lidocaine-monoethylglycinexylidide test in the liver transplant recipient.
    Potter JM, Hickman PE, Henderson A, Balderson GA, Lynch SV, Strong RW.
    Ther Drug Monit; 1996 Aug 27; 18(4):383-7. PubMed ID: 8857555
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Importance of determination of monoethylglycinexylidide (MEGX)--as a liver function test in hepatology and liver transplantation].
    Kupcová V.
    Bratisl Lek Listy; 1999 Jan 27; 100(1):49-53. PubMed ID: 10492998
    [Abstract] [Full Text] [Related]

  • 12. Use of lidocaine metabolism to test liver function during the long-term follow-up of liver transplant recipients.
    Conti F, Dousset B, Cherruau B, Guérin C, Soubrane O, Houssin D, Calmus Y.
    Clin Transplant; 2004 Jun 27; 18(3):235-41. PubMed ID: 15142042
    [Abstract] [Full Text] [Related]

  • 13. Lignocaine metabolite formation as a measure of pre-transplant liver function.
    Oellerich M, Burdelski M, Ringe B, Lamesch P, Gubernatis G, Bunzendahl H, Pichlmayr R, Herrmann H.
    Lancet; 1989 Mar 25; 1(8639):640-2. PubMed ID: 2564460
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of the monoethylglycinexylidide test in pediatric liver transplant candidates.
    Burdelski M, Schütz E, Nolte-Buchholtz S, Armstrong VW, Oellerich M.
    Ther Drug Monit; 1996 Aug 25; 18(4):378-82. PubMed ID: 8857554
    [Abstract] [Full Text] [Related]

  • 15. Selection criteria for liver transplant donors.
    Schroeder TJ, Pesce AJ, Ryckman FC, Tressler TP, Brunson ME, Pedersen SH, Tchervenkov JI, Penn I, Alexander JW, Balistreri WF.
    J Clin Lab Anal; 1991 Aug 25; 5(4):275-7. PubMed ID: 1890541
    [Abstract] [Full Text] [Related]

  • 16. Prospective multivariate analysis of donor monoethylglycine xylidide (MEGX) testing in liver transplantation. Transplantation Society of Michigan Scientific Studies Committee.
    Woodside KJ, Merion RM, Williams TC.
    Clin Transplant; 1998 Feb 25; 12(1):43-8. PubMed ID: 9541422
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Donor hyaluronic acid and MEGX levels do not accurately predict posttransplant liver function.
    Michell ID, Abdulnour I, Pzybylowski G, Bowkett J, Gleeson A, Hardy KJ, Jones RM.
    Transplant Proc; 1993 Oct 25; 25(5):2888-9. PubMed ID: 8212275
    [No Abstract] [Full Text] [Related]

  • 20. The value of the donor MEGX test in predicting liver allograft recipient outcome.
    Potter JM, Balderson GA, Hickman PE, Henderson A, Wright M, Burrow B, Lynch SV, Ong TH, Strong RW.
    Transplantation; 1994 Aug 27; 58(4):524-6. PubMed ID: 8073525
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.